Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Novartis
Argus Health
Merck
US Army
Moodys
Accenture
Mallinckrodt
Boehringer Ingelheim
Chubb
Cipla

Generated: October 18, 2017

DrugPatentWatch Database Preview

Details for Patent: 3,904,682

« Back to Dashboard

Summary for Patent: 3,904,682

Title: 2-(6'-Methoxy-2'-naphthyl)acetic acid
Abstract:2-(6'-Substituted-2'-naphthyl)acetic acid derivatives substituted at the 2-position of the acetic acid moiety with methyl, methylene or halomethylene and the salts and esters thereof have anti-inflammatory, analgesic and anti-pyretic activities.
Inventor(s): Fried; John H. (Palo Alto, CA), Harrison; Ian T. (Palo Alto, CA)
Assignee: Syntex Corporation (PM)
Application Number:05/372,028
Patent Claim Types:
see list of patent claims
Compound;

No matches for this query

International Patent Family for Patent: 3,904,682

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia1006270► Subscribe
Belgium734275► Subscribe
Belgium747812► Subscribe
Belgium751445► Subscribe
Belgium752627► Subscribe
Brazil6910380► Subscribe
Brazil6915470► Subscribe
Brazil6915472► Subscribe
Canada960668► Subscribe
Canada960689► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Healthtrust
Colorcon
Chubb
Harvard Business School
Queensland Health
UBS
Federal Trade Commission
Chinese Patent Office
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot